chr12-6044493-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000552.5(VWF):c.2282-42C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.542 in 1,601,648 control chromosomes in the GnomAD database, including 240,752 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.49 ( 20148 hom., cov: 32)
Exomes 𝑓: 0.55 ( 220604 hom. )
Consequence
VWF
NM_000552.5 intron
NM_000552.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.420
Publications
22 publications found
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
VWF Gene-Disease associations (from GenCC):
- hereditary von Willebrand diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- von Willebrand disease type 2BInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- von Willebrand disease 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- von Willebrand disease 1Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- von Willebrand disease type 2AInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- von Willebrand disease type 2MInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- von Willebrand disease 3Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- von Willebrand disease type 2NInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 12-6044493-G-T is Benign according to our data. Variant chr12-6044493-G-T is described in ClinVar as Benign. ClinVar VariationId is 256658.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.685 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.493 AC: 74953AN: 151954Hom.: 20135 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
74953
AN:
151954
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.585 AC: 135035AN: 230794 AF XY: 0.586 show subpopulations
GnomAD2 exomes
AF:
AC:
135035
AN:
230794
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.547 AC: 793387AN: 1449576Hom.: 220604 Cov.: 35 AF XY: 0.550 AC XY: 396376AN XY: 720474 show subpopulations
GnomAD4 exome
AF:
AC:
793387
AN:
1449576
Hom.:
Cov.:
35
AF XY:
AC XY:
396376
AN XY:
720474
show subpopulations
African (AFR)
AF:
AC:
9149
AN:
33188
American (AMR)
AF:
AC:
31229
AN:
43174
Ashkenazi Jewish (ASJ)
AF:
AC:
16836
AN:
25932
East Asian (EAS)
AF:
AC:
27398
AN:
39222
South Asian (SAS)
AF:
AC:
53433
AN:
84950
European-Finnish (FIN)
AF:
AC:
27306
AN:
51984
Middle Eastern (MID)
AF:
AC:
3680
AN:
5674
European-Non Finnish (NFE)
AF:
AC:
591373
AN:
1105520
Other (OTH)
AF:
AC:
32983
AN:
59932
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
19729
39458
59188
78917
98646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
16880
33760
50640
67520
84400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.493 AC: 74994AN: 152072Hom.: 20148 Cov.: 32 AF XY: 0.501 AC XY: 37251AN XY: 74320 show subpopulations
GnomAD4 genome
AF:
AC:
74994
AN:
152072
Hom.:
Cov.:
32
AF XY:
AC XY:
37251
AN XY:
74320
show subpopulations
African (AFR)
AF:
AC:
11735
AN:
41496
American (AMR)
AF:
AC:
9880
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
2230
AN:
3468
East Asian (EAS)
AF:
AC:
3623
AN:
5142
South Asian (SAS)
AF:
AC:
3149
AN:
4816
European-Finnish (FIN)
AF:
AC:
5684
AN:
10584
Middle Eastern (MID)
AF:
AC:
196
AN:
294
European-Non Finnish (NFE)
AF:
AC:
36871
AN:
67956
Other (OTH)
AF:
AC:
1135
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1844
3687
5531
7374
9218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2226
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
von Willebrand disease type 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
von Willebrand disease type 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
von Willebrand disease type 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.